Evofem Biosciences Completes Phase 3 Clinical Trial of Amphora for Prevention of Pregnancy
Go back to Evofem Biosciences Completes Phase 3 Clinical Trial of Amphora for Prevention of Pregnancy| (AMEX: EVFM) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $ | |||
| Open | $0.01 | 52 Week Low | $ | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $ | |||
| Volume | 211 | |||||
